We noticed that both DTX3L and TIRR mRNA expression levels were increased in tumor tissues compared to normal tissues from The Cancer Genome Atlas (TCGA) prostate cancer datasets, and this increase was associated with the progression of prostate cancer (Supplementary Fig. 5a). This evidence concerns the gene DTX3L and prostate carcinoma.